232 related articles for article (PubMed ID: 25059483)
21. Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders.
Pagan C; Goubran-Botros H; Delorme R; Benabou M; Lemière N; Murray K; Amsellem F; Callebert J; Chaste P; Jamain S; Fauchereau F; Huguet G; Maronde E; Leboyer M; Launay JM; Bourgeron T
Sci Rep; 2017 May; 7(1):2096. PubMed ID: 28522826
[TBL] [Abstract][Full Text] [Related]
22. Melatonin Synthesis: Acetylserotonin O-Methyltransferase (ASMT) Is Strongly Expressed in a Subpopulation of Pinealocytes in the Male Rat Pineal Gland.
Rath MF; Coon SL; Amaral FG; Weller JL; Møller M; Klein DC
Endocrinology; 2016 May; 157(5):2028-40. PubMed ID: 26950199
[TBL] [Abstract][Full Text] [Related]
23. Melatonin in autism spectrum disorders.
Rossignol DA; Frye RE
Curr Clin Pharmacol; 2014; 9(4):326-34. PubMed ID: 24050742
[TBL] [Abstract][Full Text] [Related]
24. Is ASMT a susceptibility gene for autism spectrum disorders? A replication study in European populations.
Toma C; Rossi M; Sousa I; Blasi F; Bacchelli E; Alen R; Vanhala R; Monaco AP; Järvelä I; Maestrini E;
Mol Psychiatry; 2007 Nov; 12(11):977-9. PubMed ID: 17957233
[No Abstract] [Full Text] [Related]
25. Cellular localization and kinetics of the rice melatonin biosynthetic enzymes SNAT and ASMT.
Byeon Y; Lee HY; Lee K; Park S; Back K
J Pineal Res; 2014 Jan; 56(1):107-14. PubMed ID: 24134674
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure and functional mapping of human ASMT, the last enzyme of the melatonin synthesis pathway.
Botros HG; Legrand P; Pagan C; Bondet V; Weber P; Ben-Abdallah M; Lemière N; Huguet G; Bellalou J; Maronde E; Beguin P; Haouz A; Shepard W; Bourgeron T
J Pineal Res; 2013 Jan; 54(1):46-57. PubMed ID: 22775292
[TBL] [Abstract][Full Text] [Related]
27. A congenic line of the C57BL/6J mouse strain that is proficient in melatonin synthesis.
Zhang Z; Silveyra E; Jin N; Ribelayga CP
J Pineal Res; 2018 Oct; 65(3):e12509. PubMed ID: 29768727
[TBL] [Abstract][Full Text] [Related]
28. Molecular cloning of a plant N-acetylserotonin methyltransferase and its expression characteristics in rice.
Kang K; Kong K; Park S; Natsagdorj U; Kim YS; Back K
J Pineal Res; 2011 Apr; 50(3):304-9. PubMed ID: 21210840
[TBL] [Abstract][Full Text] [Related]
29. Controlled-release melatonin, singly and combined with cognitive behavioural therapy, for persistent insomnia in children with autism spectrum disorders: a randomized placebo-controlled trial.
Cortesi F; Giannotti F; Sebastiani T; Panunzi S; Valente D
J Sleep Res; 2012 Dec; 21(6):700-9. PubMed ID: 22616853
[TBL] [Abstract][Full Text] [Related]
30. Melatonin in autism spectrum disorders: a systematic review and meta-analysis.
Rossignol DA; Frye RE
Dev Med Child Neurol; 2011 Sep; 53(9):783-792. PubMed ID: 21518346
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and management of insomnia in children with autistic spectrum disorders.
Miano S; Ferri R
Paediatr Drugs; 2010 Apr; 12(2):75-84. PubMed ID: 20218744
[TBL] [Abstract][Full Text] [Related]
32. Low melatonin production by suppression of either serotonin N-acetyltransferase or N-acetylserotonin methyltransferase in rice causes seedling growth retardation with yield penalty, abiotic stress susceptibility, and enhanced coleoptile growth under anoxic conditions.
Byeon Y; Back K
J Pineal Res; 2016 Apr; 60(3):348-59. PubMed ID: 26919041
[TBL] [Abstract][Full Text] [Related]
33. A study of aanat and asmt expression in the three-spined stickleback eye and skin: Not only "on the way to melatonin".
Pomianowski K; Gozdowska M; Burzyński A; Kalamarz-Kubiak H; Sokołowska E; Kijewska A; Kulczykowska E
Comp Biochem Physiol A Mol Integr Physiol; 2020 Mar; 241():110635. PubMed ID: 31841711
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profile associated with Asmt knockout-induced depression-like behaviors and exercise effects in mouse hypothalamus.
Liu W; Huang Z; Xia J; Cui Z; Li L; Qi Z; Liu W
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35771226
[TBL] [Abstract][Full Text] [Related]
35. Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion.
Guénolé F; Godbout R; Nicolas A; Franco P; Claustrat B; Baleyte JM
Sleep Med Rev; 2011 Dec; 15(6):379-87. PubMed ID: 21393033
[TBL] [Abstract][Full Text] [Related]
36. The Prevalence of Insomnia and the Link between Iron Metabolism Genes Polymorphisms,
Skonieczna-Żydecka K; Jamioł-Milc D; Borecki K; Stachowska E; Zabielska P; Kamińska M; Karakiewicz B
Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31936202
[TBL] [Abstract][Full Text] [Related]
37. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
[TBL] [Abstract][Full Text] [Related]
38. Melatonin: an option for managing sleep disorders in children with autism spectrum disorder.
Damiani JM; Sweet BV; Sohoni P
Am J Health Syst Pharm; 2014 Jan; 71(2):95-101. PubMed ID: 24375600
[No Abstract] [Full Text] [Related]
39. An AANAT/ASMT transgenic animal model constructed with CRISPR/Cas9 system serving as the mammary gland bioreactor to produce melatonin-enriched milk in sheep.
Ma T; Tao J; Yang M; He C; Tian X; Zhang X; Zhang J; Deng S; Feng J; Zhang Z; Wang J; Ji P; Song Y; He P; Han H; Fu J; Lian Z; Liu G
J Pineal Res; 2017 Aug; 63(1):. PubMed ID: 28273380
[TBL] [Abstract][Full Text] [Related]
40. Melatonergic system-based two-gene index is prognostic in human gliomas.
Kinker GS; Oba-Shinjo SM; Carvalho-Sousa CE; Muxel SM; Marie SK; Markus RP; Fernandes PA
J Pineal Res; 2016 Jan; 60(1):84-94. PubMed ID: 26510398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
